PMC Links for Gene (Select 1361) - PMC

Result Filters

Links from Gene

Items: 1 to 20 of 41

<< First< Prev

Page of 3

Select item 106557031.

Plasma thrombin-activatable fibrinolysis inhibitor and the 1040C/T polymorphism are risk factors for diabetic kidney disease in Chinese patients with type 2 diabetes

Qinghua Huang, Dujin Feng, Lianlian Pan, Huan Wang, Yan Wu, Bin Zhong, Jianguang Gong, Huijun Lin, Xianming Fei

PeerJ. 2023; 11: e16352. Published online 2023 Nov 14. doi: 10.7717/peerj.16352

PMCID:: PMC10655703

Abstract Article PDF–2.3M

Select item 99679892.

ProCPU Is Expressed by (Primary) Human Monocytes and Macrophages and Expression Differs between States of Differentiation and Activation

Karen Claesen, Joni De Loose, Pieter Van Wielendaele, Emilie De bruyn, Yani Sim, Sofie Thys, Ingrid De Meester, Dirk Hendriks

Int J Mol Sci. 2023 Feb; 24(4): 3725. Published online 2023 Feb 13. doi: 10.3390/ijms24043725

PMCID:: PMC9967989

Abstract Article PDF–2.8M

Select item 82523723.

Relationship Between Polymorphism of Thrombin-Activatable Fibrinolysis Inhibitor Gene +1040C/T and a Cohort of Chinese Women With Recurrent Spontaneous Abortion

Ping Fang, Decheng Cai, Lijun Du, Fei Shen, Chengfang Zhang, Meijuan Li

Clin Appl Thromb Hemost. 2021 Jan-Dec; 27: 10760296211029720. Published online 2021 Jun 30. doi: 10.1177/10760296211029720

PMCID:: PMC8252372

Abstract Article PDF–144K

Select item 73128464.

Activation of TAFI on the Surface of Streptococcus pyogenes Evokes Inflammatory Reactions by Modulating the Kallikrein/Kinin System

Sara H. Bengtson, Caroline Sandén, Matthias Mörgelin, Pauline F. Marx, Anders I. Olin, L.M. Fredrik Leeb-Lundberg, Joost C.M. Meijers, Heiko Herwald

J Innate Immun. 2008 Aug; 1(1): 18–28. Published online 2008 Jul 12. doi: 10.1159/000145543

PMCID:: PMC7312846

Abstract Article PDF–506K

Select item 67146465.

Thrombin-Activatable Fibrinolysis Inhibitor Gene Polymorphism (TAFI1040C/T) in Women With Recurrent Spontaneous Abortion

Nabil ElDanasori, Nelly Abulata, Iman A. Shaheen, Alaa M. ElGendy, Waleed El-Khayat

Clin Appl Thromb Hemost. 2018 Apr; 24(3): 532–535. Published online 2017 Feb 22. doi: 10.1177/1076029617695485

PMCID:: PMC6714646

Abstract Article PDF–118K

Select item 62601326.

A Genome-wide Study of Common and Rare Genetic Variants Associated with Circulating Thrombin Activatable Fibrinolysis Inhibitor

Tara M. Stanne, Maja Olsson, Erik Lorentzen, Annie Pedersen, Anders Gummesson, Ann Gils, Katarina Jood, Gunnar Engström, Olle Melander, Paul J. Declerck, Christina Jern

Thromb Haemost. 2018 Feb; 118(2): 298–308. Published online 2018 Jan 29. doi: 10.1160/TH17-04-0249

PMCID:: PMC6260132

Abstract Article PDF–385K

Select item 54461327.

Sex-specific effect of CPB2 Ala147Thr but not Thr325Ile variants on the risk of venous thrombosis: A comprehensive meta-analysis

Nora Zwingerman, Alejandra Medina-Rivera, Irfahan Kassam, Michael D. Wilson, Pierre-Emmanuel Morange, David-Alexandre Trégouët, France Gagnon

PLoS One. 2017; 12(5): e0177768. Published online 2017 May 26. doi: 10.1371/journal.pone.0177768

PMCID:: PMC5446132

Abstract Article PDF–2.3M

Select item 49430548.

Thrombin activatable fibrinolysis inhibitor as a bleeding predictor in liver transplantation: a pilot observational study

Wagner Luis Nedel, Edison Moraes Rodrigues Filho, Alessandro Comarú Pasqualotto

Rev Bras Ter Intensiva. 2016 Apr-Jun; 28(2): 161–166. doi: 10.5935/0103-507X.20160031

PMCID:: PMC4943054

Abstract Article PDF–167K

Select item 40261239.

Association between polymorphisms in the flanking region of the TAFI gene and atherosclerotic cerebral infarction in a Chinese population

You Li, Zhiliang Zeng, Jianghao Zhao, Guoda Ma, Lili Cui, Hua Tao, Zhijun Lin, Yanyan Chen, Bin Zhao, Yusen Chen, Keshen Li

Lipids Health Dis. 2014; 13: 80. Published online 2014 May 13. doi: 10.1186/1476-511X-13-80

PMCID:: PMC4026123

Abstract Article PDF–209K

Select item 392673410.

In vitro evaluation of clot quality and stability in a model of severe thrombocytopenia: effect of fibrinogen, factor XIII and thrombin-activatable fibrinolysis inhibitor

Boris Shenkman, Yulia Einav, Tami Livnat, Ivan Budnik, Uriel Martinowitz

Blood Transfus. 2014 Jan; 12(1): 78–84. doi: 10.2450/2013.0068-13

PMCID:: PMC3926734

Abstract Article PDF–875K

Select item 350227611.

Is there any role of thrombin activatable fibrinolysis inhibitor in the development of a hypercoagulable state in gastric cancer

Mehmet Eser, Metin Kement, Salim Balin, Cihan Coskun, Umut Kefeli, Mahmut Gumus, Yunus Emre Altuntas, Necmi Kurt, Alparslan Mayadagli

World J Surg Oncol. 2012; 10: 180. Published online 2012 Aug 31. doi: 10.1186/1477-7819-10-180

PMCID:: PMC3502276

Abstract Article PDF–170K

Select item 299225812.

Flexibility of the Thrombin-activatable Fibrinolysis Inhibitor Pro-domain Enables Productive Binding of Protein Substrates

Zuzana Valnickova, Laura Sanglas, Joan L. Arolas, Steen V. Petersen, Christine Schar, Daniel Otzen, Francesc X. Aviles, F. Xavier Gomis-Rüth, Jan J. Enghild

J Biol Chem. 2010 Dec 3; 285(49): 38243–38250. Published online 2010 Sep 29. doi: 10.1074/jbc.M110.150342

PMCID:: PMC2992258

Abstract Article PDF–1.6M

Select item 268857213.

Low thrombin activatable fibrinolysis inhibitor activity levels are associated with an increased risk of a first myocardial infarction in men

Mirjam E. Meltzer, Carine J.M. Doggen, Philip G. de Groot, Joost C.M. Meijers, Frits R. Rosendaal, Ton Lisman

Haematologica. 2009 Jun; 94(6): 811–818. Published online 2009 Apr 18. doi: 10.3324/haematol.2008.002386

PMCID:: PMC2688572

Abstract Article PDF–145K

Select item 259219814.

A GENOME-WIDE EXPLORATION SUGGESTS AN OLIGOGENIC MODEL OF INHERITANCE FOR THE TAFI ACTIVITY AND ITS ANTIGEN LEVELS

Maria Sabater-Lleal, Alfonso Buil, Juan Carlos Souto, Laura Almasy, Montserrat Borrell, Mark Lathrop, John Blangero, Jordi Fontcuberta, José Manuel Soria

Hum Genet. Author manuscript; available in PMC 2009 Aug 1.

Published in final edited form as: Hum Genet. 2008 Aug; 124(1): 81–88. Published online 2008 Jun 18. doi: 10.1007/s00439-008-0527-3

PMCID:: PMC2592198

Abstract Article PDF–318K

Select item 227637215.

Thrombin-activable Fibrinolysis Inhibitor Zymogen Does Not Play a Significant Role in the Attenuation of Fibrinolysis

Jonathan H. Foley, Paula Kim, Michael E. Nesheim

J Biol Chem. 2008 Apr 4; 283(14): 8863–8867. doi: 10.1074/jbc.M800127200

PMCID:: PMC2276372

Abstract Article PDF–293K

Select item 220091116.

Thrombin-thrombomodulin connects coagulation and fibrinolysis: more than an in vitro phenomenon

Tanya M. Binette, Fletcher B. Taylor, Jr, Glenn Peer, Laszlo Bajzar

Blood. 2007 Nov 1; 110(9): 3168–3175. Prepublished online 2007 Jul 20. doi: 10.1182/blood-2007-03-078824

PMCID:: PMC2200911

Abstract Article

Select item 1101824217.

A challenging issue in COVID-19 infection: The relationship between PA1-1 and TAFI levels in patients with coagulation disorder: A retrospective and observational study

Nilgun Altin, Pinar Tiğlioğlu, Tulay Unver Ulusoy, Fevzi Nuri Aydin, İrem Kar, Busra Karakoc, Gulten Utebey

Medicine (Baltimore) 2024 Apr 12; 103(15): e37802. Published online 2024 Apr 12. doi: 10.1097/MD.0000000000037802

PMCID:: PMC11018242

Abstract Article PDF–585K

Select item 310330618.

Kinetics of Activated Thrombin-activatable Fibrinolysis Inhibitor (TAFIa)-catalyzed Cleavage of C-terminal Lysine Residues of Fibrin Degradation Products and Removal of Plasminogen-binding Sites

Jonathan H. Foley, Paul F. Cook, Michael E. Nesheim

J Biol Chem. 2011 Jun 3; 286(22): 19280–19286. Published online 2011 Apr 5. doi: 10.1074/jbc.M110.215061

PMCID:: PMC3103306

Abstract Article PDF–953K

Select item 268411519.

Biochemical characterization of bovine plasma thrombin-activatable fibrinolysis inhibitor (TAFI)

Zuzana Valnickova, Morten Thaysen-Andersen, Peter Højrup, Trine Christensen, Kristian W Sanggaard, Torsten Kristensen, Jan J Enghild

BMC Biochem. 2009; 10: 13. Published online 2009 May 5. doi: 10.1186/1471-2091-10-13

PMCID:: PMC2684115

Abstract Article PDF–2.0M

Select item 266202720.

The Crystal Structure of Thrombin-activable Fibrinolysis Inhibitor (TAFI) Provides the Structural Basis for Its Intrinsic Activity and the Short Half-life of TAFIa

Kanchan Anand, Irantzu Pallares, Zuzana Valnickova, Trine Christensen, Josep Vendrell, K. Ulrich Wendt, Herman A. Schreuder, Jan J. Enghild, Francesc X. Avilés

J Biol Chem. 2008 Oct 24; 283(43): 29416–29423. doi: 10.1074/jbc.M804003200